Evidence map›Paper›PMID 38457119›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2024

Refining antimicrobial photodynamic therapy: effect of charge distribution and central metal ion in fluorinated porphyrins on effective control of planktonic and biofilm bacterial forms.

Barbara Pucelik, Agata Barzowska, Adam Sułek, Mateusz Werłos, Janusz M Dąbrowski

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Barbara PucelikFaculty of Chemistry, Jagiellonian University, Kraków, Poland. barbara.pucelik@uj.edu.pl.ORCID http://orcid.org/0000-0002-0235-6532
Agata BarzowskaMalopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland.ORCID http://orcid.org/0000-0002-2353-5089
Adam SułekFaculty of Chemistry, Jagiellonian University, Kraków, Poland.ORCID http://orcid.org/0000-0002-4248-1047
Mateusz WerłosFaculty of Chemistry, Jagiellonian University, Kraków, Poland.ORCID http://orcid.org/0000-0001-7924-6887
Janusz M DąbrowskiFaculty of Chemistry, Jagiellonian University, Kraków, Poland. jdabrows@chemia.uj.edu.pl.ORCID http://orcid.org/0000-0002-8791-7035

Funding

Narodowe Centrum Nauki 2016/22/E/NZ7/00420
6 · The paper itself

Abstract

Antibiotic resistance represents a pressing global health challenge, now acknowledged as a critical concern within the framework of One Health. Photodynamic inactivation of microorganisms (PDI) offers an attractive, non-invasive approach known for its flexibility, independence from microbial resistance patterns, broad-spectrum efficacy, and minimal risk of inducing resistance. Various photosensitizers, including porphyrin derivatives have been explored for pathogen eradication. In this context, we present the synthesis, spectroscopic and photophysical characteristics as well as antimicrobial properties of a palladium(II)-porphyrin derivative (PdF

Indexed as

Anti-Infective AgentsPhotochemotherapyPorphyrinsAnimalsBiofilmsHumansMammalsOxygenPalladiumPhotosensitizing AgentsPlanktonReactive Oxygen SpeciesSinglet OxygenStaphylococcus aureusAnti-Infective AgentsOxygenPalladiumPhotosensitizing AgentsPorphyrinsReactive Oxygen SpeciesSinglet OxygenBiofilmMetalloporphyrinPhotodynamic inactivation (PDI)PhotosensitizerPorphyrinReactive oxygen species (ROS)Singlet oxygen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.